Arrowhead Pharmaceuticals (STU:HDP1) Accounts Payable & Accrued Expense : €54.57 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Accounts Payable & Accrued Expense?

Arrowhead Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2023 (€87.70 Mil) to Dec. 2023 (€54.87 Mil) and declined from Dec. 2023 (€54.87 Mil) to Mar. 2024 (€54.57 Mil).

Arrowhead Pharmaceuticals's annual accounts payable & accrued expense increased from Sep. 2021 (€28.25 Mil) to Sep. 2022 (€62.60 Mil) and increased from Sep. 2022 (€62.60 Mil) to Sep. 2023 (€87.70 Mil).

Arrowhead Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Accounts Payable & Accrued Expense Chart

Arrowhead Pharmaceuticals Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

17.35

17.22

28.25

62.60

87.70

Arrowhead Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															51.00	46.61	87.70	54.87	54.57

Arrowhead Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Arrowhead Pharmaceuticals (STU:HDP1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ARWR:USA

Address

177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105

Website

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (STU:HDP1) Headlines

No Headlines